Neogenomics Inc

NEO NASDAQ Santé & Biotech États-Unis US64049M2098
11.15 $
2.79 %

Neogenomics Inc se concentre sur la prestation de services de recherche en oncologie génétique, incluant des tests moléculaires et de cytogénétique pour le diagnostic et le traitement du cancer.

Performance & Momentum

6 Months 6.46 %
1 Year 57.71 %
3 Years 31.47 %
5 Years 74.14 %

Similar stocks to Neogenomics Inc

Anantys Community

Be the first to share your analysis on Neogenomics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases